Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Rankin

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|November 1, 1987
Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancerE M Rankin, C Harvey, R K Knight, et al.
British Medical Journal (Clinical Research Ed.)|October 27, 1984
Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphomaE M Rankin, A Hekman, M R Hardeman, et al.
Blood|June 1, 1985
Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodiesE M Rankin, A Hekman, R Somers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2007
Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancerW A Verborg, L R Campbell, M S Highley, et al.
British Journal of Cancer|July 2, 1998
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaJ M Bonfrer, C M Korse, O E Nieweg, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
A mathematical model of the development of drug resistance to cancer chemotherapyB G Birkhead, E M Rankin, S Gallivan, et al.
Nephron|January 1, 1992
Acute interstitial nephritis during continuous intravenous administration of low-dose interleukin-2M J Diekman, L T Vlasveld, R T Krediet, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1984
Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemiaE M Rankin, D M Jones, F G Lawston, et al.
British Journal of Cancer|September 13, 2007
First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of actionW Verborg, H Thomas, D Bissett, et al.
British Journal of Cancer|July 1, 1990
A pilot study of quinidine and epirubicin in the treatment of advanced breast cancerR D Jones, D J Kerr, A N Harnett, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|November 1, 1987
Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancerE M Rankin, C Harvey, R K Knight, et al.
British Medical Journal (Clinical Research Ed.)|October 27, 1984
Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphomaE M Rankin, A Hekman, M R Hardeman, et al.
Blood|June 1, 1985
Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodiesE M Rankin, A Hekman, R Somers, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 22, 2007
Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancerW A Verborg, L R Campbell, M S Highley, et al.
British Journal of Cancer|July 2, 1998
The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaJ M Bonfrer, C M Korse, O E Nieweg, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
A mathematical model of the development of drug resistance to cancer chemotherapyB G Birkhead, E M Rankin, S Gallivan, et al.
Nephron|January 1, 1992
Acute interstitial nephritis during continuous intravenous administration of low-dose interleukin-2M J Diekman, L T Vlasveld, R T Krediet, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1984
Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemiaE M Rankin, D M Jones, F G Lawston, et al.
British Journal of Cancer|September 13, 2007
First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of actionW Verborg, H Thomas, D Bissett, et al.
British Journal of Cancer|July 1, 1990
A pilot study of quinidine and epirubicin in the treatment of advanced breast cancerR D Jones, D J Kerr, A N Harnett, et al.
Pageof 6